0000097476--12-312021Q3FALSE00000974762021-01-012021-09-30xbrli:shares00000974762021-10-19iso4217:USD00000974762021-07-012021-09-3000000974762020-07-012020-09-3000000974762020-01-012020-09-30iso4217:USDxbrli:shares00000974762021-09-3000000974762020-12-3100000974762019-12-3100000974762020-09-30txn:reportable_segment0000097476txn:AnalogMember2021-07-012021-09-300000097476txn:AnalogMember2020-07-012020-09-300000097476txn:AnalogMember2021-01-012021-09-300000097476txn:AnalogMember2020-01-012020-09-300000097476txn:EmbeddedProcessingMember2021-07-012021-09-300000097476txn:EmbeddedProcessingMember2020-07-012020-09-300000097476txn:EmbeddedProcessingMember2021-01-012021-09-300000097476txn:EmbeddedProcessingMember2020-01-012020-09-300000097476us-gaap:AllOtherSegmentsMember2021-07-012021-09-300000097476us-gaap:AllOtherSegmentsMember2020-07-012020-09-300000097476us-gaap:AllOtherSegmentsMember2021-01-012021-09-300000097476us-gaap:AllOtherSegmentsMember2020-01-012020-09-300000097476country:US2021-07-012021-09-300000097476country:US2020-07-012020-09-300000097476country:US2021-01-012021-09-300000097476country:US2020-01-012020-09-300000097476srt:AsiaMember2021-07-012021-09-300000097476srt:AsiaMember2020-07-012020-09-300000097476srt:AsiaMember2021-01-012021-09-300000097476srt:AsiaMember2020-01-012020-09-300000097476us-gaap:EMEAMember2021-07-012021-09-300000097476us-gaap:EMEAMember2020-07-012020-09-300000097476us-gaap:EMEAMember2021-01-012021-09-300000097476us-gaap:EMEAMember2020-01-012020-09-300000097476country:JP2021-07-012021-09-300000097476country:JP2020-07-012020-09-300000097476country:JP2021-01-012021-09-300000097476country:JP2020-01-012020-09-300000097476txn:RestOfWorldMember2021-07-012021-09-300000097476txn:RestOfWorldMember2020-07-012020-09-300000097476txn:RestOfWorldMember2021-01-012021-09-300000097476txn:RestOfWorldMember2020-01-012020-09-300000097476country:CN2021-07-012021-09-300000097476country:CN2020-07-012020-09-300000097476country:CN2021-01-012021-09-300000097476country:CN2020-01-012020-09-300000097476us-gaap:FairValueInputsLevel2Member2021-09-30xbrli:pure0000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MoneyMarketFundsMemberus-gaap:AvailableforsaleSecuritiesMember2021-09-300000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MoneyMarketFundsMemberus-gaap:AvailableforsaleSecuritiesMember2020-12-310000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2021-09-300000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:AvailableforsaleSecuritiesMember2020-12-310000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:AvailableforsaleSecuritiesMember2021-09-300000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:AvailableforsaleSecuritiesMember2020-12-310000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-09-300000097476us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:AvailableforsaleSecuritiesMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310000097476us-gaap:MutualFundMemberus-gaap:EstimateOfFairValueFairValueDisclosureMembertxn:TradingSecuritiesMember2021-09-300000097476us-gaap:MutualFundMemberus-gaap:EstimateOfFairValueFairValueDisclosureMembertxn:TradingSecuritiesMember2020-12-310000097476us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-09-300000097476us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000097476us-gaap:EquityMethodInvestmentsMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2021-09-300000097476us-gaap:EquityMethodInvestmentsMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2020-12-310000097476txn:NonMarketableEquityInvestmentsMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2021-09-300000097476txn:NonMarketableEquityInvestmentsMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2020-12-310000097476us-gaap:CashMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2021-09-300000097476us-gaap:CashMemberus-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember2020-12-310000097476us-gaap:FairValueInputsLevel3Member2021-09-300000097476us-gaap:FairValueInputsLevel3Member2020-12-310000097476us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-09-300000097476us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-09-300000097476us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300000097476us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310000097476us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310000097476us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310000097476us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-09-300000097476us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-09-300000097476us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300000097476us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310000097476us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310000097476us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310000097476us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-09-300000097476us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-09-300000097476us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300000097476us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310000097476us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310000097476us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310000097476us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-09-300000097476us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-09-300000097476us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300000097476us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310000097476us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310000097476us-gaap:MutualFundMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membertxn:DeferredCompensationMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membertxn:DeferredCompensationMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMembertxn:DeferredCompensationMember2021-09-300000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membertxn:DeferredCompensationMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membertxn:DeferredCompensationMember2020-12-310000097476us-gaap:FairValueMeasurementsRecurringMembertxn:DeferredCompensationMember2020-12-310000097476us-gaap:PensionPlansDefinedBenefitMembercountry:US2021-07-012021-09-300000097476us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-07-012020-09-300000097476country:USus-gaap:DefinedBenefitPostretirementHealthCoverageMember2021-07-012021-09-300000097476country:USus-gaap:DefinedBenefitPostretirementHealthCoverageMember2020-07-012020-09-300000097476us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2021-07-012021-09-300000097476us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-07-012020-09-300000097476us-gaap:PensionPlansDefinedBenefitMembercountry:US2021-01-012021-09-300000097476us-gaap:PensionPlansDefinedBenefitMembercountry:US2020-01-012020-09-300000097476country:USus-gaap:DefinedBenefitPostretirementHealthCoverageMember2021-01-012021-09-300000097476country:USus-gaap:DefinedBenefitPostretirementHealthCoverageMember2020-01-012020-09-300000097476us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2021-01-012021-09-300000097476us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2020-01-012020-09-300000097476us-gaap:RevolvingCreditFacilityMember2021-09-30txn:seriesOfDebt0000097476us-gaap:SeniorNotesMember2021-09-300000097476txn:FixedOnePointOneTwoFivePercentNotesDue2026Member2021-09-300000097476txn:FixedOnePointNinePercentNotesDue2031Member2021-09-300000097476txn:FixedTwoPointSevenPercentNotesDue2051Member2021-09-300000097476txn:FixedTwoPointSevenFivePercentNotesDueTwoThousandAndTwentyOneMember2021-02-012021-02-280000097476txn:FixedTwoPointSevenFivePercentNotesDueTwoThousandAndTwentyOneMember2021-09-300000097476txn:FixedTwoPointSevenFivePercentNotesDueTwoThousandAndTwentyOneMember2020-12-310000097476txn:FixedOnePointEightFivePercentNotesDueTwoThousandAndTwentyTwoMember2021-09-300000097476txn:FixedOnePointEightFivePercentNotesDueTwoThousandAndTwentyTwoMember2020-12-310000097476txn:FixedTwoPointTwoFivePercentNotesDueTwoThousandAndTwentyThreeMember2021-09-300000097476txn:FixedTwoPointTwoFivePercentNotesDueTwoThousandAndTwentyThreeMember2020-12-310000097476txn:FixedTwoPointSixTwoFivePercentNotesDueTwoThousandAndTwentyFourMember2021-09-300000097476txn:FixedTwoPointSixTwoFivePercentNotesDueTwoThousandAndTwentyFourMember2020-12-310000097476txn:FixedOnePointThreeSevenFivePercentNotesDueTwoThousandTwentyFiveMember2021-09-300000097476txn:FixedOnePointThreeSevenFivePercentNotesDueTwoThousandTwentyFiveMember2020-12-310000097476txn:FixedOnePointOneTwoFivePercentNotesDue2026Member2020-12-310000097476txn:FixedTwoPointNineZeroPercentNotesDueTwoThousandAndTwentySevenMember2021-09-300000097476txn:FixedTwoPointNineZeroPercentNotesDueTwoThousandAndTwentySevenMember2020-12-310000097476txn:FixedRate225Due2029Member2021-09-300000097476txn:FixedRate225Due2029Member2020-12-310000097476txn:FixedRate175Due2030Member2021-09-300000097476txn:FixedRate175Due2030Member2020-12-310000097476txn:FixedOnePointNinePercentNotesDue2031Member2020-12-310000097476txn:FixedThreePointEightSevenFivePercentNotesDueTwoThousandAndThirtyNineMember2021-09-300000097476txn:FixedThreePointEightSevenFivePercentNotesDueTwoThousandAndThirtyNineMember2020-12-310000097476txn:FixedFourPointOneFivePercentNotesDueTwoThousandAndFortyEightMember2021-09-300000097476txn:FixedFourPointOneFivePercentNotesDueTwoThousandAndFortyEightMember2020-12-310000097476txn:FixedTwoPointSevenPercentNotesDue2051Member2020-12-310000097476us-gaap:CommonStockMember2020-12-310000097476us-gaap:AdditionalPaidInCapitalMember2020-12-310000097476us-gaap:RetainedEarningsMember2020-12-310000097476us-gaap:TreasuryStockMember2020-12-310000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000097476us-gaap:RetainedEarningsMember2021-01-012021-03-3100000974762021-01-012021-03-310000097476us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000097476us-gaap:TreasuryStockMember2021-01-012021-03-310000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000097476us-gaap:CommonStockMember2021-03-310000097476us-gaap:AdditionalPaidInCapitalMember2021-03-310000097476us-gaap:RetainedEarningsMember2021-03-310000097476us-gaap:TreasuryStockMember2021-03-310000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000097476us-gaap:RetainedEarningsMember2021-04-012021-06-3000000974762021-04-012021-06-300000097476us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300000097476us-gaap:TreasuryStockMember2021-04-012021-06-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000097476us-gaap:CommonStockMember2021-06-300000097476us-gaap:AdditionalPaidInCapitalMember2021-06-300000097476us-gaap:RetainedEarningsMember2021-06-300000097476us-gaap:TreasuryStockMember2021-06-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000097476us-gaap:RetainedEarningsMember2021-07-012021-09-300000097476us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300000097476us-gaap:TreasuryStockMember2021-07-012021-09-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000097476us-gaap:CommonStockMember2021-09-300000097476us-gaap:AdditionalPaidInCapitalMember2021-09-300000097476us-gaap:RetainedEarningsMember2021-09-300000097476us-gaap:TreasuryStockMember2021-09-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300000097476us-gaap:CommonStockMember2019-12-310000097476us-gaap:AdditionalPaidInCapitalMember2019-12-310000097476us-gaap:RetainedEarningsMember2019-12-310000097476us-gaap:TreasuryStockMember2019-12-310000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000097476us-gaap:RetainedEarningsMember2020-01-012020-03-3100000974762020-01-012020-03-310000097476us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000097476us-gaap:TreasuryStockMember2020-01-012020-03-310000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310000097476us-gaap:CommonStockMember2020-03-310000097476us-gaap:AdditionalPaidInCapitalMember2020-03-310000097476us-gaap:RetainedEarningsMember2020-03-310000097476us-gaap:TreasuryStockMember2020-03-310000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310000097476us-gaap:RetainedEarningsMember2020-04-012020-06-3000000974762020-04-012020-06-300000097476us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300000097476us-gaap:TreasuryStockMember2020-04-012020-06-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300000097476us-gaap:CommonStockMember2020-06-300000097476us-gaap:AdditionalPaidInCapitalMember2020-06-300000097476us-gaap:RetainedEarningsMember2020-06-300000097476us-gaap:TreasuryStockMember2020-06-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300000097476us-gaap:RetainedEarningsMember2020-07-012020-09-300000097476us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000097476us-gaap:TreasuryStockMember2020-07-012020-09-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000097476us-gaap:CommonStockMember2020-09-300000097476us-gaap:AdditionalPaidInCapitalMember2020-09-300000097476us-gaap:RetainedEarningsMember2020-09-300000097476us-gaap:TreasuryStockMember2020-09-300000097476us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300000097476us-gaap:SubsequentEventMember2021-10-012021-10-270000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000097476us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
|
|
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2021
|
|
|
|
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the transition period from ___________ to
___________
Commission File Number 001-03761
TEXAS INSTRUMENTS INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
75-0289970 |
|
|
(State of Incorporation) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
|
12500 TI Boulevard, Dallas, Texas
|
|
75243 |
|
|
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
|
|
|
Registrant’s telephone number, including area code
214-479-3773
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value $1.00 |
TXN |
The Nasdaq Global Select Market |
Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
Registrant was required to submit such files). Yes
☒ No ☐
Indicate by check mark whether the Registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer |
☒ |
|
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☐ |
Emerging growth company |
☐ |
|
|
|
|
|
|
|
|
If an emerging growth company, indicate by check mark if the
Registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act |
☐ |
Indicate by check mark whether the Registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
923,526,047
Number of shares of Registrant’s common stock outstanding as
of
October 19, 2021
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION
ITEM 1. Financial statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended |
|
For Nine Months Ended |
Consolidated Statements of Income |
|
September 30, |
|
September 30, |
(Millions of dollars, except share and per-share
amounts) |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Revenue |
|
$ |
4,643 |
|
|
$ |
3,817 |
|
|
$ |
13,512 |
|
|
$ |
10,385 |
|
Cost of revenue (COR) |
|
1,491 |
|
|
1,364 |
|
|
4,486 |
|
|
3,762 |
|
Gross profit |
|
3,152 |
|
|
2,453 |
|
|
9,026 |
|
|
6,623 |
|
Research and development (R&D) |
|
388 |
|
|
386 |
|
|
1,165 |
|
|
1,142 |
|
Selling, general and administrative (SG&A) |
|
412 |
|
|
407 |
|
|
1,262 |
|
|
1,225 |
|
Acquisition charges |
|
47 |
|
|
51 |
|
|
142 |
|
|
151 |
|
Restructuring charges/other |
|
— |
|
|
— |
|
|
— |
|
|
24 |
|
Operating profit |
|
2,305 |
|
|
1,609 |
|
|
6,457 |
|
|
4,081 |
|
Other income (expense), net (OI&E) |
|
15 |
|
|
27 |
|
|
134 |
|
|
151 |
|
Interest and debt expense |
|
45 |
|
|
49 |
|
|
135 |
|
|
142 |
|
Income before income taxes |
|
2,275 |
|
|
1,587 |
|
|
6,456 |
|
|
4,090 |
|
Provision for income taxes |
|
328 |
|
|
234 |
|
|
825 |
|
|
183 |
|
Net income |
|
$ |
1,947 |
|
|
$ |
1,353 |
|
|
$ |
5,631 |
|
|
$ |
3,907 |
|
|
|
|
|
|
|
|
|
|
Earnings per common share (EPS): |
|
|
|
|
|
|
|
|
Basic |
|
$ |
2.10 |
|
|
$ |
1.47 |
|
|
$ |
6.08 |
|
|
$ |
4.22 |
|
Diluted |
|
$ |
2.07 |
|
|
$ |
1.45 |
|
|
$ |
5.99 |
|
|
$ |
4.17 |
|
|
|
|
|
|
|
|
|
|
Average shares outstanding (millions): |
|
|
|
|
|
|
|
|
Basic |
|
923 |
|
|
917 |
|
|
923 |
|
|
921 |
|
Diluted |
|
936 |
|
|
929 |
|
|
936 |
|
|
933 |
|
|
|
|
|
|
|
|
|
|
A portion of net income is allocated to unvested restricted stock
units (RSUs) on which we pay dividend equivalents. Diluted EPS is
calculated using the following: |
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,947 |
|
|
$ |
1,353 |
|
|
$ |
5,631 |
|
|
$ |
3,907 |
|
Income allocated to RSUs |
|
(9) |
|
|
(6) |
|
|
(24) |
|
|
(19) |
|
Income allocated to common stock for diluted EPS |
|
$ |
1,938 |
|
|
$ |
1,347 |
|
|
$ |
5,607 |
|
|
$ |
3,888 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes. |
|
|
|
|
|
|
|
|
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended |
|
For Nine Months Ended |
Consolidated Statements of Comprehensive Income |
|
September 30, |
|
September 30, |
(Millions of dollars) |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Net income |
|
$ |
1,947 |
|
|
$ |
1,353 |
|
|
$ |
5,631 |
|
|
$ |
3,907 |
|
Other comprehensive income (loss) |
|
|
|
|
|
|
|
|
Net actuarial losses of defined benefit plans: |
|
|
|
|
|
|
|
|
Adjustments, net of tax effect of ($1) and $3; ($8) and
$4
|
|
3 |
|
|
(7) |
|
|
24 |
|
|
(8) |
|
Recognized within net income, net of tax effect of ($2) and ($2);
($7) and ($7)
|
|
8 |
|
|
7 |
|
|
24 |
|
|
21 |
|
Prior service credit of defined benefit plans: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized within net income, net of tax effect of $0 and $0; $0
and $0
|
|
(1) |
|
|
(1) |
|
|
(1) |
|
|
(1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss), net of taxes |
|
10 |
|
|
(1) |
|
|
47 |
|
|
12 |
|
Total comprehensive income |
|
$ |
1,957 |
|
|
$ |
1,352 |
|
|
$ |
5,678 |
|
|
$ |
3,919 |
|
|
|
|
|
|
|
|
|
|
See accompanying notes. |
|
|
|
|
|
|
|
|
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
Consolidated Balance Sheets |
|
2021 |
|
2020 |
(Millions of dollars, except share amounts) |
|
|
|
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
|
$ |
5,663 |
|
|
$ |
3,107 |
|
Short-term investments |
|
4,119 |
|
|
3,461 |
|
Accounts receivable, net of allowances of ($9) and
($11)
|
|
1,653 |
|
|
1,414 |
|
Raw materials |
|
224 |
|
|
180 |
|
Work in process |
|
1,034 |
|
|
964 |
|
Finished goods |
|
605 |
|
|
811 |
|
Inventories |
|
1,863 |
|
|
1,955 |
|
Prepaid expenses and other current assets |
|
287 |
|
|
302 |
|
Total current assets |
|
13,585 |
|
|
10,239 |
|
Property, plant and equipment at cost |
|
6,661 |
|
|
5,781 |
|
Accumulated depreciation |
|
(2,640) |
|
|
(2,512) |
|
Property, plant and equipment |
|
4,021 |
|
|
3,269 |
|
Goodwill |
|
4,362 |
|
|
4,362 |
|
Acquisition-related intangibles |
|
9 |
|
|
152 |
|
Deferred tax assets |
|
309 |
|
|
343 |
|
Capitalized software licenses |
|
88 |
|
|
122 |
|
Overfunded retirement plans |
|
252 |
|
|
246 |
|
Other long-term assets |
|
647 |
|
|
618 |
|
Total assets |
|
$ |
23,273 |
|
|
$ |
19,351 |
|
|
|
|
|
|
Liabilities and stockholders’ equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Current portion of long-term debt |
|
$ |
500 |
|
|
$ |
550 |
|
Accounts payable |
|
596 |
|
|
415 |
|
Accrued compensation |
|
665 |
|
|
767 |
|
Income taxes payable |
|
101 |
|
|
134 |
|
Accrued expenses and other liabilities |
|
551 |
|
|
524 |
|
Total current liabilities |
|
2,413 |
|
|
2,390 |
|
Long-term debt |
|
7,239 |
|
|
6,248 |
|
Underfunded retirement plans |
|
129 |
|
|
131 |
|
Deferred tax liabilities |
|
86 |
|
|
90 |
|
Other long-term liabilities |
|
1,255 |
|
|
1,305 |
|
Total liabilities |
|
11,122 |
|
|
10,164 |
|
Stockholders’ equity: |
|
|
|
|
Preferred stock, $25 par value. Authorized – 10,000,000
shares; none issued
|
|
— |
|
|
— |
|
Common stock, $1 par value. Authorized – 2,400,000,000
shares
|
|
|
|
|
Shares issued – 1,740,815,939
|
|
1,741 |
|
|
1,741 |
|
Paid-in capital |
|
2,563 |
|
|
2,333 |
|
Retained earnings |
|
44,847 |
|
|
42,051 |
|
Treasury common stock at cost |
|
|
|
|
Shares: September 30, 2021 – 817,400,928; December 31, 2020 –
821,461,787
|
|
(36,687) |
|
|
(36,578) |
|
Accumulated other comprehensive income (loss), net of taxes
(AOCI) |
|
(313) |
|
|
(360) |
|
Total stockholders’ equity |
|
12,151 |
|
|
9,187 |
|
Total liabilities and stockholders’ equity |
|
$ |
23,273 |
|
|
$ |
19,351 |
|
|
|
|
|
|
See accompanying notes. |
|
|
|
|
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Nine Months Ended |
Consolidated Statements of Cash Flows |
|
September 30, |
(Millions of dollars) |
|
2021 |
|
2020 |
Cash flows from operating activities |
|
|
|
|
Net income |
|
$ |
5,631 |
|
|
$ |
3,907 |
|
Adjustments to net income: |
|
|
|
|
Depreciation |
|
555 |
|
|
553 |
|
Amortization of acquisition-related intangibles |
|
142 |
|
|
151 |
|
Amortization of capitalized software |
|
44 |
|
|
45 |
|
Stock compensation |
|
180 |
|
|
182 |
|
Gains on sales of assets |
|
(7) |
|
|
(3) |
|
Deferred taxes |
|
19 |
|
|
(115) |
|
Increase (decrease) from changes in: |
|
|
|
|
Accounts receivable |
|
(239) |
|
|
(318) |
|
Inventories |
|
92 |
|
|
(71) |
|
Prepaid expenses and other current assets |
|
99 |
|
|
— |
|
Accounts payable and accrued expenses |
|
87 |
|
|
60 |
|
Accrued compensation |
|
(103) |
|
|
(48) |
|
Income taxes payable |
|
(54) |
|
|
(316) |
|
Changes in funded status of retirement plans |
|
48 |
|
|
16 |
|
Other |
|
(95) |
|
|
(29) |
|
Cash flows from operating activities |
|
6,399 |
|
|
4,014 |
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Capital expenditures |
|
(1,180) |
|
|
(437) |
|
Proceeds from asset sales |
|
7 |
|
|
3 |
|
Purchases of short-term investments |
|
(6,427) |
|
|
(3,435) |
|
Proceeds from short-term investments |
|
5,770 |
|
|
3,958 |
|
Other |
|
(36) |
|
|
(15) |
|
Cash flows from investing activities |
|
(1,866) |
|
|
74 |
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
Proceeds from issuance of long-term debt |
|
1,495 |
|
|
1,498 |
|
Repayment of debt |
|
(550) |
|
|
(500) |
|
Dividends paid |
|
(2,824) |
|
|
(2,489) |
|
Stock repurchases |
|
(385) |
|
|
(2,538) |
|
Proceeds from common stock transactions |
|
325 |
|
|
356 |
|
Other |
|
(38) |
|
|
(30) |
|
Cash flows from financing activities |
|
(1,977) |
|
|
(3,703) |
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
2,556 |
|
|
385 |
|
Cash and cash equivalents at beginning of period |
|
3,107 |
|
|
2,437 |
|
Cash and cash equivalents at end of period |
|
$ |
5,663 |
|
|
$ |
2,822 |
|
|
|
|
|
|
See accompanying notes. |
|
|
|
|
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Notes to financial statements
1.
Description of business, including segment and geographic area
information
We design, make and sell semiconductors to electronics designers
and manufacturers all over the world. We have two reportable
segments, Analog and Embedded Processing, each of which represents
groups of similar products that are combined on the basis of
similar design and development requirements, product
characteristics, manufacturing processes and distribution
channels.
•Analog
semiconductors change real-world signals, such as sound,
temperature, pressure or images, by conditioning them, amplifying
them and often converting them to a stream of digital data that can
be processed by other semiconductors, such as embedded processors.
Analog semiconductors are also used to manage power in all
electronic equipment by converting, distributing, storing,
discharging, isolating and measuring electrical energy, whether the
equipment is plugged into a wall or using a battery. Our Analog
segment consists of two major product lines: Power and Signal
Chain.
•Embedded
Processing products are the digital “brains” of many types of
electronic equipment. They are designed to handle specific tasks
and can be optimized for various combinations of performance, power
and cost, depending on the application.
We report the results of our remaining business activities in
Other. Other includes operating segments that do not meet the
quantitative thresholds for individually reportable segments and
cannot be aggregated with other operating segments. Other includes
DLP®
products, calculators and custom ASIC products.
Our centralized manufacturing and support organizations, such as
facilities, procurement and logistics, provide support to our
operating segments, including those in Other. Costs incurred by
these organizations, including depreciation, are charged to the
segments on a per-unit basis. Consequently, depreciation expense is
not an independently identifiable component within the segments’
results and, therefore, is not provided.
Segment information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended |
|
For Nine Months Ended |
|
September 30, |
|
September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Revenue: |
|
|
|
|
|
|
|
Analog |
$ |
3,548 |
|
|
$ |
2,865 |
|
|
$ |
10,292 |
|
|
$ |
7,759 |
|
Embedded Processing |
738 |
|
|
651 |
|
|
2,285 |
|
|
1,850 |
|
Other |
357 |
|
|
301 |
|
|
935 |
|
|
776 |
|
Total revenue |
$ |
4,643 |
|
|
$ |
3,817 |
|
|
$ |
13,512 |
|
|
$ |
10,385 |
|
|
|
|
|
|
|
|
|
Operating profit: |
|
|
|
|
|
|
|
Analog |
$ |
1,871 |
|
|
$ |
1,320 |
|
|
$ |
5,295 |
|
|
$ |
3,398 |
|
Embedded Processing |
282 |
|
|
187 |
|
|
881 |
|
|
494 |
|
Other (a) |
152 |
|
|
102 |
|
|
281 |
|
|
189 |
|
Total operating profit |
$ |
2,305 |
|
|
$ |
1,609 |
|
|
$ |
6,457 |
|
|
$ |
4,081 |
|
(a)Includes
acquisition charges and restructuring charges/other
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Geographic area information
The following geographic area information includes revenue, based
on product shipment destination. The geographic revenue information
does not necessarily reflect end demand by geography because our
products tend to be shipped to the locations where our customers
manufacture their products.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended |
|
For Nine Months Ended |
|
September 30, |
|
September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Revenue: |
|
|
|
|
|
|
|
United States |
$ |
515 |
|
|
$ |
440 |
|
|
$ |
1,437 |
|
|
$ |
1,179 |
|
Asia (a) |
3,082 |
|
|
2,555 |
|
|
8,933 |
|
|
6,756 |
|
Europe, Middle East and Africa |
683 |
|
|
578 |
|
|
2,061 |
|
|
1,648 |
|
Japan |
242 |
|
|
140 |
|
|
716 |
|
|
523 |
|
Rest of world |
121 |
|
|
104 |
|
|
365 |
|
|
279 |
|
Total revenue |
$ |
4,643 |
|
|
$ |
3,817 |
|
|
$ |
13,512 |
|
|
$ |
10,385 |
|
(a)Revenue
from products shipped into China was $2.5 billion and
$2.2 billion in the third quarters of 2021 and 2020,
respectively, and $7.3 billion and $5.7 billion in the first
nine months of 2021 and 2020, respectively, which includes
shipments to customers that manufacture in China and then export
end products to their customers around the world, as well as
distributors that transship inventory through China to service
other countries.
2.
Basis of presentation and significant accounting policies and
practices
Basis of presentation
The consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in the
United States (GAAP) and on the same basis as the audited financial
statements included in our annual report on Form 10-K for the year
ended December 31, 2020. The Consolidated Statements of Income,
Comprehensive Income and Cash Flows for the periods ended September
30, 2021 and 2020, and the Consolidated Balance Sheet as of
September 30, 2021, are not audited but reflect all adjustments
that are of a normal recurring nature and are necessary for a fair
statement of the results of the periods shown. Certain information
and note disclosures normally included in annual consolidated
financial statements have been omitted pursuant to the rules and
regulations of the U.S. Securities and Exchange Commission. Because
the consolidated interim financial statements do not include all of
the information and notes required by GAAP for a complete set of
financial statements, they should be read in conjunction with the
audited consolidated financial statements and notes included in our
annual report on Form 10-K for the year ended December 31, 2020.
The results for the three- and nine-month periods are not
necessarily indicative of a full year’s results.
Significant accounting policies and practices
Earnings per share (EPS)
We use the two-class method for calculating EPS because the
restricted stock units (RSUs) we grant are participating securities
containing non-forfeitable rights to receive dividend
equivalents. Under the two-class method, a portion of net
income is allocated to RSUs and excluded from the calculation of
income allocated to common stock.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Computation and reconciliation of earnings per common share are as
follows (shares in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended September 30, |
|
2021 |
|
2020 |
|
Net Income |
|
Shares |
|
EPS |
|
Net Income |
|
Shares |
|
EPS |
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
1,947 |
|
|
|
|
|
|
$ |
1,353 |
|
|
|
|
|
Income allocated to RSUs |
(9) |
|
|
|
|
|
|
(6) |
|
|
|
|
|
Income allocated to common stock |
$ |
1,938 |
|
|
923 |
|
|
$ |
2.10 |
|
|
$ |
1,347 |
|
|
917 |
|
|
$ |
1.47 |
|
Dilutive effect of stock compensation plans |
|
|
13 |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
1,947 |
|
|
|
|
|
|
$ |
1,353 |
|
|
|
|
|
Income allocated to RSUs |
(9) |
|
|
|
|
|
|
(6) |
|
|
|
|
|
Income allocated to common stock |
$ |
1,938 |
|
|
936 |
|
|
$ |
2.07 |
|
|
$ |
1,347 |
|
|
929 |
|
|
$ |
1.45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Nine Months Ended September 30, |
|
2021 |
|
2020 |
|
Net Income |
|
Shares |
|
EPS |
|
Net Income |
|
Shares |
|
EPS |
Basic EPS: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
5,631 |
|
|
|
|
|
|
$ |
3,907 |
|
|
|
|
|
Income allocated to RSUs |
(23) |
|
|
|
|
|
|
(19) |
|
|
|
|
|
Income allocated to common stock |
$ |
5,608 |
|
|
923 |
|
|
$ |
6.08 |
|
|
$ |
3,888 |
|
|
921 |
|
|
$ |
4.22 |
|
Dilutive effect of stock compensation plans |
|
|
13 |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
5,631 |
|
|
|
|
|
|
$ |
3,907 |
|
|
|
|
|
Income allocated to RSUs |
(24) |
|
|
|
|
|
|
(19) |
|
|
|
|
|
Income allocated to common stock |
$ |
5,607 |
|
|
936 |
|
|
$ |
5.99 |
|
|
$ |
3,888 |
|
|
933 |
|
|
$ |
4.17 |
|
Potentially dilutive securities representing 2 million and 3
million shares of common stock that were outstanding during the
third quarters of 2021 and 2020, respectively, and 3 million and 4
million shares outstanding during the first nine months of 2021 and
2020, respectively, were excluded from the computation of diluted
earnings per common share during these periods because their effect
would have been anti-dilutive.
Derivatives and hedging
We use derivative financial instruments to manage exposure to
foreign exchange risk. These instruments are primarily forward
foreign currency exchange contracts, which are used as economic
hedges to reduce the earnings impact that exchange rate
fluctuations may have on our non-U.S. dollar net balance sheet
exposures. Gains and losses from changes in the fair value of these
forward foreign currency exchange contracts are credited or charged
to OI&E. We do not apply hedge accounting to our foreign
currency derivative instruments.
We are exposed to variability in compensation charges related to
certain deferred compensation obligations to employees. We use
total return swaps to economically hedge this exposure and offset
the related compensation expense, recognizing changes in the value
of the swaps and the related deferred compensation liabilities in
SG&A.
In connection with the issuance of long-term debt, we may use
financial derivatives such as treasury-rate lock agreements that
are recognized in AOCI and amortized over the life of the related
debt. The results of these derivative transactions have not been
material.
We do not use derivatives for speculative or trading
purposes.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Fair values of financial instruments
The fair values of our derivative financial instruments were not
material as of September 30, 2021. Our investments in cash
equivalents, short-term investments and certain long-term
investments, as well as our deferred compensation liabilities, are
carried at fair value. The carrying values for other current
financial assets and liabilities, such as accounts receivable and
accounts payable, approximate fair value due to the short maturity
of such instruments. As of September 30, 2021, the carrying value
of long-term debt, including the current portion, was
$7.74 billion, and the estimated fair value was
$8.43 billion. The estimated fair value is measured using
broker-dealer quotes, which are Level 2 inputs. See Note 4 for a
description of fair value and the definition of Level 2
inputs.
3.
Income taxes
Our estimated annual effective tax rate is about 14%, which does
not include discrete tax items. This differs from the 21% U.S.
statutory corporate tax rate due to the effect of U.S. tax
benefits.
Provision for income taxes is based on the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended |
|
For Nine Months Ended |
|
September 30, |
|
September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Taxes calculated using the estimated annual effective tax
rate |
$ |
337 |
|
|
$ |
231 |
|
|
$ |
934 |
|
|
$ |
561 |
|
Discrete tax items |
(9) |
|
|
3 |
|
|
(109) |
|
|
(378) |
|
Provision for income taxes |
$ |
328 |
|
|
$ |
234 |
|
|
$ |
825 |
|
|
$ |
183 |
|
|
|
|
|
|
|
|
|
Effective tax rate |
14 |
% |
|
15 |
% |
|
13 |
% |
|
4 |
% |
Our provision for income taxes for the first nine months of 2020
included a $249 million discrete tax benefit for the
settlement of a depreciation-related uncertain tax position.
Accrued interest of $46 million related to this uncertain tax
position was reversed and included in OI&E.
4.
Valuation of debt and equity investments and certain
liabilities
Investments measured at fair value
Available-for-sale debt investments, money market funds and mutual
funds are stated at fair value, which is generally based on market
prices or broker quotes. See
Fair-value considerations
below. Unrealized gains and losses from available-for-sale
debt securities are recorded as an increase or decrease, net of
taxes, in AOCI on our Consolidated Balance Sheets and any credit
losses on available-for-sale debt securities are recorded as an
allowance for credit losses with an offset recognized in OI&E
in our Consolidated Statements of Income.
Our mutual funds hold a variety of debt and equity investments
intended to generate returns that offset changes in certain
deferred compensation liabilities. We record changes in the
fair value of these mutual funds and the related deferred
compensation liabilities in SG&A.
Other investments
Our other investments include equity-method investments and
non-marketable equity investments, which are not measured at fair
value. These investments consist of interests in venture
capital funds and other non-marketable equity
securities. Gains and losses from equity-method investments
are recognized in OI&E based on our ownership share of the
investee’s financial results.
Non-marketable equity securities are measured at cost with
adjustments for observable changes in price or impairments. Gains
and losses on non-marketable equity investments are recognized in
OI&E.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details of our investments are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
|
December 31, 2020 |
|
Cash and Cash Equivalents |
|
Short-Term Investments |
|
Long-Term Investments |
|
Cash and Cash Equivalents |
|
Short-Term Investments |
|
Long-Term Investments |
Measured at fair value: |
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
$ |
2,132 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
886 |
|
|
$ |
— |
|
|
$ |
— |
|
Corporate obligations |
1,136 |
|
|
1,109 |
|
|
— |
|
|
256 |
|
|
257 |
|
|
— |
|
U.S. government and agency securities |
1,140 |
|
|
2,587 |
|
|
— |
|
|
1,340 |
|
|
3,054 |
|
|
— |
|
Non-U.S. government and agency securities |
385 |
|
|
423 |
|
|
— |
|
|
— |
|
|
150 |
|
|
— |
|
Mutual funds |
— |
|
|
— |
|
|
15 |
|
|
— |
|
|
— |
|
|
18 |
|
Total |
4,793 |
|
|
4,119 |
|
|
15 |
|
|
2,482 |
|
|
3,461 |
|
|
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other measurement basis: |
|
|
|
|
|
|
|
|
|
|
|
Equity-method investments |
— |
|
|
— |
|
|
54 |
|
|
— |
|
|
— |
|
|
27 |
|
Non-marketable equity investments |
— |
|
|
— |
|
|
4 |
|
|
— |
|
|
— |
|
|
4 |
|
Cash on hand |
870 |
|
|
— |
|
|
— |
|
|
625 |
|
|
— |
|
|
— |
|
Total |
$ |
5,663 |
|
|
$ |
4,119 |
|
|
$ |
73 |
|
|
$ |
3,107 |
|
|
$ |
3,461 |
|
|
$ |
49 |
|
As of September 30, 2021, and December 31, 2020, unrealized gains
and losses associated with our available-for-sale investments were
not material. We did not recognize any credit losses related to
available-for-sale investments for the first nine months of 2021
and 2020. All of our debt securities classified as available for
sale as of September 30, 2021, have maturities within one
year.
Proceeds from sales, redemptions and maturities of short-term
available-for-sale investments were $1.32 billion and
$510 million for the third quarters of 2021 and 2020,
respectively, and $5.77 billion and $3.71 billion for the
first nine months of 2021 and 2020, respectively. Gross realized
gains and losses from these sales were not material.
During the first nine months of 2020, we entered into total return
swaps to economically hedge the variability of certain deferred
compensation obligations to employees. As a result, we received
proceeds of $253 million from the sale of investments in
mutual funds that were previously being utilized to offset this
exposure.
Fair-value considerations
We measure and report certain financial assets and liabilities at
fair value on a recurring basis. Fair value is defined as the price
that would be received to sell an asset or paid to transfer a
liability (an exit price) in the principal or most advantageous
market for the asset or liability in an orderly transaction between
market participants on the measurement date.
The three-level hierarchy described below indicates the extent and
level of judgment used to estimate fair-value
measurements.
•Level
1
– Uses unadjusted quoted prices that are available in active
markets for identical assets or liabilities as of the reporting
date.
•Level
2
– Uses inputs other than Level 1 that are either directly or
indirectly observable as of the reporting date through correlation
with market data, including quoted prices for similar assets and
liabilities in active markets and quoted prices in markets that are
not active. Level 2 also includes assets and liabilities that are
valued using models or other pricing methodologies that do not
require significant judgment since the input assumptions used in
the models, such as interest rates and volatility factors, are
corroborated by readily observable data. We utilize a third-party
data service to provide Level 2 valuations. We verify these
valuations for reasonableness relative to unadjusted quotes
obtained from brokers or dealers based on observable prices for
similar assets in active markets.
•Level
3
– Uses inputs that are unobservable, supported by little or no
market activity and reflect the use of significant management
judgment. These values are generally determined using pricing
models that utilize management estimates of market participant
assumptions. As of September 30, 2021, and December 31, 2020, we
had no Level 3 assets or liabilities.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
The following are our assets and liabilities that were accounted
for at fair value on a recurring basis. These tables do not include
cash on hand, assets held by our postretirement plans, or assets
and liabilities that are measured at historical cost or any basis
other than fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
|
December 31, 2020 |
|
Level 1 |
|
Level 2 |
|
Total |
|
Level 1 |
|
Level 2 |
|
Total |
Assets: |
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
$ |
2,132 |
|
|
$ |
— |
|
|
$ |
2,132 |
|
|
$ |
886 |
|
|
$ |
— |
|
|
$ |
886 |
|
Corporate obligations |
— |
|
|
2,245 |
|
|
2,245 |
|
|
— |
|
|
513 |
|
|
513 |
|
U.S. government and agency securities |
3,326 |
|
|
401 |
|
|
3,727 |
|
|
4,394 |
|
|
— |
|
|
4,394 |
|
Non-U.S. government and agency securities |
— |
|
|
808 |
|
|
808 |
|
|
— |
|
|
150 |
|
|
150 |
|
Mutual funds |
15 |
|
|
— |
|
|
15 |
|
|
18 |
|
|
— |
|
|
18 |
|
Total assets |
$ |
5,473 |
|
|
$ |
3,454 |
|
|
$ |
8,927 |
|
|
$ |
5,298 |
|
|
$ |
663 |
|
|
$ |
5,961 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
Deferred compensation |
$ |
367 |
|
|
$ |
— |
|
|
$ |
367 |
|
|
$ |
350 |
|
|
$ |
— |
|
|
$ |
350 |
|
Total liabilities |
$ |
367 |
|
|
$ |
— |
|
|
$ |
367 |
|
|
$ |
350 |
|
|
$ |
— |
|
|
$ |
350 |
|
5.
Postretirement benefit plans
Expenses related to defined benefit and retiree health care benefit
plans are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Defined Benefit |
|
U.S. Retiree Health Care |
|
Non-U.S. Defined Benefit |
For Three Months Ended September 30, |
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Service cost |
$ |
5 |
|
|
$ |
5 |
|
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
9 |
|
|
$ |
9 |
|
Interest cost |
8 |
|
|
7 |
|
|
3 |
|
|
3 |
|
|
9 |
|
|
9 |
|
Expected return on plan assets |
(8) |
|
|
(9) |
|
|
(2) |
|
|
(2) |
|
|
(20) |
|
|
(20) |
|
Recognized net actuarial loss |
3 |
|
|
1 |
|
|
— |
|
|
— |
|
|
2 |
|
|
4 |
|
Amortization of prior service cost (credit) |
— |
|
|
— |
|
|
(1) |
|
|
(1) |
|
|
— |
|
|
— |
|
Net periodic benefit costs |
8 |
|
|
4 |
|
|
— |
|
|
1 |
|
|
— |
|
|
2 |
|
Settlement losses |
4 |
|
|
3 |
|
|
— |
|
|
— |
|
|
1 |
|
|
1 |
|
Total, including other postretirement losses |
$ |
12 |
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
1 |
|
|
$ |
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Defined Benefit |
|
U.S. Retiree Health Care |
|
Non-U.S. Defined Benefit |
For Nine Months Ended September 30, |
2021 |
|
2020 |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Service cost |
$ |
16 |
|
|
$ |
14 |
|
|
$ |
2 |
|
|
$ |
2 |
|
|
$ |
27 |
|
|
$ |
25 |
|
Interest cost |
23 |
|
|
24 |
|
|
8 |
|
|
9 |
|
|
28 |
|
|
28 |
|
Expected return on plan assets |
(25) |
|
|
(27) |
|
|
(8) |
|
|
(8) |
|
|
(61) |
|
|
(58) |
|
Recognized net actuarial loss |
11 |
|
|
5 |
|
|
— |
|
|
— |
|
|
6 |
|
|
11 |
|
Amortization of prior service cost (credit) |
— |
|
|
— |
|
|
(1) |
|
|
(1) |
|
|
— |
|
|
— |
|
Net periodic benefit costs |
25 |
|
|
16 |
|
|
1 |
|
|
2 |
|
|
— |
|
|
6 |
|
Settlement losses |
12 |
|
|
10 |
|
|
— |
|
|
— |
|
|
2 |
|
|
2 |
|
Total, including other postretirement losses |
$ |
37 |
|
|
$ |
26 |
|
|
$ |
1 |
|
|
$ |
2 |
|
|
$ |
2 |
|
|
$ |
8 |
|
6.
Debt and lines of credit
Short-term borrowings
We maintain a line of credit to support commercial paper
borrowings, if any, and to provide additional liquidity through
bank loans. As of September 30, 2021, we had a variable-rate
revolving credit facility from a consortium of investment-grade
banks that allows us to borrow up to $2 billion until March
2024. The interest rate on borrowings under this credit facility,
if drawn, is indexed to the applicable London Interbank Offered
Rate (LIBOR). As of September 30, 2021, our credit facility was
undrawn, and we had no commercial paper outstanding.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Long-term debt
In September 2021, we issued three series of senior unsecured notes
for an aggregate principal amount of $1.50 billion, consisting
of:
•$500 million
of 1.125% notes due in 2026;
•$500 million
of 1.90% notes due in 2031; and
•$500 million
of 2.70% notes due in 2051.
We incurred $10 million of issuance costs. The proceeds of the
offering were $1.50 billion, net of the original issuance
discounts, which will be used for general corporate
purposes.
In February 2021, we retired $550 million of maturing
debt.
Long-term debt outstanding is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
2021 |
|
2020 |
Notes due 2021 at 2.75%
|
$ |
— |
|
|
$ |
550 |
|
Notes due 2022 at 1.85%
|
500 |
|
|
500 |
|
Notes due 2023 at 2.25%
|
500 |
|
|
500 |
|
Notes due 2024 at 2.625%
|
300 |
|
|
300 |
|
Notes due 2025 at 1.375%
|
750 |
|
|
750 |
|
Notes due 2026 at 1.125%
|
500 |
|
|
— |
|
Notes due 2027 at 2.90%
|
500 |
|
|
500 |
|
Notes due 2029 at 2.25%
|
750 |
|
|
750 |
|
Notes due 2030 at 1.75%
|
750 |
|
|
750 |
|
Notes due 2031 at 1.90%
|
500 |
|
|
— |
|
Notes due 2039 at 3.875%
|
750 |
|
|
750 |
|
Notes due 2048 at 4.15%
|
1,500 |
|
|
1,500 |
|
Notes due 2051 at 2.70%
|
500 |
|
|
— |
|
Total debt |
7,800 |
|
|
6,850 |
|
Net unamortized discounts, premiums and issuance costs |
(61) |
|
|
(52) |
|
Total debt, including net unamortized discounts, premiums and
issuance costs |
7,739 |
|
|
6,798 |
|
Current portion of long-term debt |
(500) |
|
|
(550) |
|
Long-term debt |
$ |
7,239 |
|
|
$ |
6,248 |
|
Interest and debt expense was $45 million and
$49 million for the third quarters of 2021 and 2020,
respectively, and $135 million and $142 million for the
first nine months of 2021 and 2020, respectively. This was net of
the amortized discounts, premiums and issuance costs. Capitalized
interest was not material.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
7.
Stockholders’ equity
Changes in equity are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
Paid-in Capital |
|
Retained Earnings |
|
Treasury Common Stock |
|
AOCI |
Balance, December 31, 2020 |
$ |
1,741 |
|
|
$ |
2,333 |
|
|
$ |
42,051 |
|
|
$ |
(36,578) |
|
|
$ |
(360) |
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
1,753 |
|
|
— |
|
|
— |
|
Dividends declared and paid ($1.02 per share)
|
— |
|
|
— |
|
|
(940) |
|
|
— |
|
|
— |
|
Common stock issued for stock-based awards |
— |
|
|
(3) |
|
|
— |
|
|
199 |
|
|
— |
|
Stock repurchases |
— |
|
|
— |
|
|
— |
|
|
(100) |
|
|
— |
|
Stock compensation |
— |
|
|
61 |
|
|
— |
|
|
— |
|
|
— |
|
Other comprehensive income (loss), net of taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
13 |
|
Dividend equivalents on RSUs |
— |
|
|
— |
|
|
(4) |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Balance, March 31, 2021 |
1,741 |
|
|
2,391 |
|
|
42,860 |
|
|
(36,479) |
|
|
(347) |
|
|
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
1,931 |
|
|
— |
|
|
— |
|
Dividends declared and paid ($1.02 per share)
|
— |
|
|
— |
|
|
(942) |
|
|
— |
|
|
— |
|
Common stock issued for stock-based awards |
— |
|
|
25 |
|
|
— |
|
|
29 |
|
|
— |
|
Stock repurchases |
— |
|
|
— |
|
|
— |
|
|
(146) |
|
|
— |
|
Stock compensation |
— |
|
|
69 |
|
|
— |
|
|
— |
|
|
— |
|
Other comprehensive income (loss), net of taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
24 |
|
Dividend equivalents on RSUs |
— |
|
|
— |
|
|
(4) |
|
|
— |
|
|
— |
|
Other |
— |
|
|
— |
|
|
1 |
|
|
— |
|
|
— |
|
Balance, June 30, 2021 |
1,741 |
|
|
2,485 |
|
|
43,846 |
|
|
(36,596) |
|
|
(323) |
|
|
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
1,947 |
|
|
— |
|
|
— |
|
Dividends declared and paid ($1.02 per share)
|
— |
|
|
— |
|
|
(942) |
|
|
— |
|
|
— |
|
Common stock issued for stock-based awards |
— |
|
|
27 |
|
|
— |
|
|
48 |
|
|
— |
|
Stock repurchases |
— |
|
|
— |
|
|
— |
|
|
(139) |
|
|
— |
|
Stock compensation |
— |
|
|
50 |
|
|
— |
|
|
— |
|
|
— |
|
Other comprehensive income (loss), net of taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
10 |
|
Dividend equivalents on RSUs |
— |
|
|
— |
|
|
(3) |
|
|
— |
|
|
— |
|
Other |
— |
|
|
1 |
|
|
(1) |
|
|
— |
|
|
— |
|
Balance, September 30, 2021 |
$ |
1,741 |
|
|
$ |
2,563 |
|
|
$ |
44,847 |
|
|
$ |
(36,687) |
|
|
$ |
(313) |
|
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
Paid-in Capital |
|
Retained Earnings |
|
Treasury Common Stock |
|
AOCI |
Balance, December 31, 2019 |
$ |
1,741 |
|
|
$ |
2,110 |
|
|
$ |
39,898 |
|
|
$ |
(34,495) |
|
|
$ |
(347) |
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
1,174 |
|
|
— |
|
|
— |
|
Dividends declared and paid ($0.90 per share)
|
— |
|
|
— |
|
|
(841) |
|
|
— |
|
|
— |
|
Common stock issued for stock-based awards |
— |
|
|
(77) |
|
|
— |
|
|
223 |
|
|
— |
|
Stock repurchases |
— |
|
|
— |
|
|
— |
|
|
(1,730) |
|
|
— |
|
Stock compensation |
— |
|
|
63 |
|
|
— |
|
|
— |
|
|
— |
|
Other comprehensive income (loss), net of taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
19 |
|
Dividend equivalents on RSUs |
— |
|
|
— |
|
|
(4) |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Balance, March 31, 2020 |
1,741 |
|
|
2,096 |
|
|
40,227 |
|
|
(36,002) |
|
|
(328) |
|
|
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
1,380 |
|
|
— |
|
|
— |
|
Dividends declared and paid ($0.90 per share)
|
— |
|
|
— |
|
|
(823) |
|
|
— |
|
|
— |
|
Common stock issued for stock-based awards |
— |
|
|
17 |
|
|
— |
|
|
70 |
|
|
— |
|
Stock repurchases |
— |
|
|
— |
|
|
— |
|
|
(793) |
|
|
— |
|
Stock compensation |
— |
|
|
69 |
|
|
— |
|
|
— |
|
|
— |
|
Other comprehensive income (loss), net of taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(6) |
|
Dividend equivalents on RSUs |
— |
|
|
— |
|
|
(4) |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Balance, June 30, 2020 |
1,741 |
|
|
2,182 |
|
|
40,780 |
|
|
(36,725) |
|
|
(334) |
|
|
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
1,353 |
|
|
— |
|
|
— |
|
Dividends declared and paid ($0.90 per share)
|
— |
|
|
— |
|
|
(825) |
|
|
— |
|
|
— |
|
Common stock issued for stock-based awards |
— |
|
|
26 |
|
|
— |
|
|
97 |
|
|
— |
|
Stock repurchases |
— |
|
|
— |
|
|
— |
|
|
(15) |
|
|
— |
|
Stock compensation |
— |
|
|
50 |
|
|
— |
|
|
— |
|
|
— |
|
Other comprehensive income (loss), net of taxes |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1) |
|
Dividend equivalents on RSUs |
— |
|
|
— |
|
|
(3) |
|
|
— |
|
|
— |
|
Other |
— |
|
|
(1) |
|
|
— |
|
|
— |
|
|
— |
|
Balance, September 30, 2020 |
$ |
1,741 |
|
|
$ |
2,257 |
|
|
$ |
41,305 |
|
|
$ |
(36,643) |
|
|
$ |
(335) |
|
8.
Contingencies
Indemnification guarantees
We routinely sell products with an intellectual property
indemnification included in the terms of sale. Historically, we
have had only minimal, infrequent losses associated with these
indemnities. Consequently, we cannot reasonably estimate any future
liabilities that may result.
Warranty costs/product liabilities
We accrue for known product-related claims if a loss is probable
and can be reasonably estimated. During the periods presented,
there have been no material accruals or payments regarding product
warranty or product liability. Historically, we have experienced a
low rate of payments on product claims. Although we cannot predict
the likelihood or amount of any future claims, we do not
believe they will have a material adverse effect on our financial
condition, results of operations or liquidity. Our stated
warranties for semiconductor products obligate us to repair,
replace or credit the purchase price of a covered product back to
the buyer. Product claim consideration may exceed the price of our
products.
TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
General
We are subject to various legal and administrative proceedings.
Although it is not possible to predict the outcome of these
matters, we believe that the results of these proceedings will not
have a material adverse effect on our financial condition, results
of operations or liquidity.
9.
Supplemental financial information
Property, plant and equipment at cost
In October 2021, we completed our acquisition of Micron
Technology’s 300-millimeter semiconductor factory in Lehi, Utah,
for cash consideration of about $900 million.
Details on amounts reclassified out of accumulated other
comprehensive income (loss), net of taxes, to net
income
Our Consolidated Statements of Comprehensive Income include items
that have been recognized within net income during the third
quarters and first nine months of 2021 and 2020. The table below
details where these transactions are recorded in our Consolidated
Statements of Income.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Three Months Ended |
|
For Nine Months Ended |
|
Impact to Related Statement of Income Lines |
|
September 30, |
|
September 30, |
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
Net actuarial losses of defined benefit plans: |
|
|
|
|
|
|
|
|
|
Recognized net actuarial loss and settlement losses (a) |
$ |
10 |
|
|
$ |
9 |
|
|
$ |
31 |
|
|
$ |
28 |
|
|
Decrease to OI&E |
Tax effect |
(2) |
|
|
(2) |
|
|
(7) |
|
|
(7) |
|
|
Decrease to provision for income taxes |
Recognized within net income, net of taxes |
$ |
8 |
|
|
$ |
7 |
|
|
$ |
24 |
|
|
$ |
21 |
|
|
Decrease to net income |
|
|
|
|
|
|
|
|
|
|
Prior service credit of defined benefit plans: |
|
|
|
|
|
|
|
|
|
Amortization of prior service credit (a) |
$ |
(1) |
|
|
$ |
(1) |
|
|
$ |
(1) |
|
|
$ |
(1) |
|
|
Increase to OI&E |
Tax effect |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
Increase to provision for income taxes |
Recognized within net income, net of taxes |
$ |
(1) |
|
|
$ |
(1) |
|
|
$ |
(1) |
|
|
$ |
(1) |
|
|
Increase to net income |
(a)Detailed
in Note 5.
Stock compensation
Total shares of 1,064,600 and 6,163,997 were issued from treasury
shares during the third quarter and first nine months of 2021,
respectively, related to stock compensation.
ITEM 2. Management’s discussion and analysis of financial condition
and results of operations
Overview
We design, make and sell semiconductors to electronics designers
and manufacturers all over the world. Technology is the foundation
of our company, but ultimately, our objective and the best metric
to measure progress and generate long-term value for owners is the
growth of free cash flow per share.
Our strategy to maximize free cash flow per share growth has three
elements:
1.A
great business model that is focused on analog and embedded
processing products and built around four sustainable competitive
advantages. The four sustainable competitive advantages are
powerful in combination and provide tangible benefits:
i.A
strong foundation of manufacturing and technology that provides
lower costs and greater control of our supply chain.
ii.A
broad portfolio of analog and embedded processing products that
offers more opportunity per customer and more value for our
investments.
iii.The
reach of our market channels that gives access to more customers
and more of their design projects, leading to the opportunity to
sell more of our products into each design and gives us better
insight and knowledge of customer needs.
iv.Diversity
and longevity of our products, markets and customer positions that
provide less single point dependency and longer returns on our
investments.
Together, these competitive advantages help position TI in a unique
class of companies capable of generating and returning significant
amounts of cash for our owners. We make our investments with an eye
towards long-term strengthening and leveraging of these
advantages.
2.Discipline
in allocating capital to the best opportunities. This spans how we
select R&D projects, develop new capabilities like TI.com,
invest in new manufacturing capacity or how we think about
acquisitions and returning cash to our owners.
3.Efficiency,
which means constantly striving for more output for every dollar
spent.
We believe that our business model with the combined effect of our
four competitive advantages sets TI apart from our peers and will
for a long time to come. We will invest to strengthen our
competitive advantages, be disciplined in capital allocation and
stay diligent in our pursuit of efficiencies. Finally, we will
remain focused on the belief that long-term growth of free cash
flow per share is the ultimate measure to generate
value.
Management’s discussion and analysis of financial condition and
results of operations (MD&A) should be read in conjunction with
the financial statements and the related notes that appear
elsewhere in this document. In the following discussion of our
results of operations:
•Our
segments represent groups of similar products that are combined on
the basis of similar design and development requirements, product
characteristics, manufacturing processes and distribution channels,
and how management allocates resources and measures results. See
Note 1 to the financial statements for more information regarding
our segments.
•When
we discuss our results:
◦Unless
otherwise noted, changes in our revenue are attributable to changes
in customer demand, which are evidenced by fluctuations in shipment
volumes.
◦New
products do not tend to have a significant impact on our revenue in
any given period because we sell such a large number of
products.
◦From
time to time, our revenue and gross profit are affected by changes
in demand for higher-priced or lower-priced products, which we
refer to as changes in the “mix” of products shipped.
◦Because
we own much of our manufacturing capacity, a significant portion of
our operating cost is fixed. When factory loadings decrease, our
fixed costs are spread over reduced output and, absent other
circumstances, our profit margins decrease. Conversely, as factory
loadings increase, our fixed costs are spread over increased output
and, absent other circumstances, our profit margins increase.
Increases and decreases in factory loadings tend to correspond to
increases and decreases in demand.
•For
an explanation of free cash flow and the term “annual operating tax
rate,” see the Non-GAAP financial information section.
•All
dollar amounts in the tables are stated in millions of U.S.
dollars.
The coronavirus (COVID-19) pandemic and its effects are impacting
and will likely continue to impact market conditions and business
operations across industries worldwide, including at TI. Therefore,
we remain cautious about how the economy might behave for the next
few years and continue to monitor potential impact on our
operations.
Performance summary
Our third quarter revenue was $4.64 billion, net income was
$1.95 billion and earnings per share (EPS) were
$2.07.
Revenue increased 22% from the same quarter a year ago due to
strong demand in industrial, automotive and personal electronics.
Analog revenue grew 24% and Embedded Processing grew 13% from the
same quarter a year ago.
Our cash flow from operations of $8.5 billion for the trailing
12 months again underscored the strength of our business model.
Free cash flow for the same period was $7.1 billion and 41% of
revenue. This reflects the quality of our product portfolio, as
well as the efficiency of our manufacturing strategy, including the
benefit of 300-millimeter production.
We returned $4.2 billion to shareholders in the past 12 months
through dividends and stock repurchases. Over the same period, our
dividend represented 53% of free cash flow, underscoring its
sustainability. In September, we announced we would increase our
dividend by 13%.
Results of operations – third quarter 2021 compared with third
quarter 2020
Revenue of $4.64 billion increased $826 million, or 22%,
due to higher revenue from Analog and, to a lesser extent, Embedded
Processing.
Gross profit of $3.15 billion was up $699 million, or 28%,
primarily due to higher revenue. As a percentage of revenue, gross
profit increased to 67.9% from 64.3%.
Operating expenses (R&D and SG&A) were $800 million
compared with $793 million.
Acquisition charges were $47 million compared with
$51 million and were non-cash.
Operating profit was $2.31 billion, or 49.6% of revenue,
compared with $1.61 billion, or 42.2% of revenue.
OI&E was $15 million of income compared with
$27 million of income.
Our provision for income taxes was $328 million compared with
$234 million. This increase was due to higher income before
income taxes. Our annual operating tax rate, which does not include
discrete tax items, was 14% in both periods. We use “annual
operating tax rate” to describe the estimated annual effective tax
rate, which differs from the 21% U.S. statutory corporate tax rate
due to the effect of U.S. tax benefits.
Net income was $1.95 billion compared with $1.35 billion.
EPS was $2.07 compared with $1.45.
Third quarter 2021 segment results
Our segment results compared with the year-ago quarter are as
follows:
Analog (includes Power and Signal Chain product lines)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q3 2021 |
|
Q3 2020 |
|
Change |
Revenue |
$ |
3,548 |
|
|
$ |
2,865 |
|
|
24 |
% |
Operating profit |
1,871 |
|
|
1,320 |
|
|
42 |
% |
Operating profit % of revenue |
52.7 |
% |
|
46.1 |
% |
|
|
Analog revenue increased in both product lines, led by Signal
Chain. Operating profit increased primarily due to higher revenue
and associated gross profit.
Embedded Processing (includes microcontrollers and
processors)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q3 2021 |
|
Q3 2020 |
|
Change |
Revenue |
$ |
738 |
|
|
$ |
651 |
|
|
13 |
% |
Operating profit |
282 |
|
|
187 |
|
|
51 |
% |
Operating profit % of revenue |
38.2 |
% |
|
28.7 |
% |
|
|
Embedded Processing revenue increased. Operating profit increased
primarily due to higher revenue and associated gross
profit.
Other (includes DLP®
products, calculators and custom ASIC products)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q3 2021 |
|
Q3 2020 |
|
Change |
Revenue |
$ |
357 |
|
|
$ |
301 |
|
|
19 |
% |
Operating profit* |
152 |
|
|
102 |
|
|
49 |
% |
Operating profit % of revenue |
42.6 |
% |
|
33.9 |
% |
|
|
* Includes acquisition charges and restructuring
charges/other |
Other revenue increased $56 million, and operating profit
increased $50 million.
Results of operations – first nine months of 2021 compared with
first nine months of 2020
Revenue of $13.51 billion increased $3.13 billion, or 30%, due to
higher revenue from Analog and, to a lesser extent, Embedded
Processing.
Gross profit of $9.03 billion was up $2.40 billion, or 36%,
primarily due to higher revenue. As a percentage of revenue, gross
profit increased to 66.8% from 63.8%.
Operating expenses were $2.43 billion compared with $2.37
billion.
Acquisition charges were $142 million compared with $151 million
and were non-cash.
Operating profit was $6.46 billion, or 47.8% of revenue, compared
with $4.08 billion, or 39.3% of revenue.
OI&E was $134 million of income compared with $151 million of
income.
Our provision for income taxes was $825 million compared with $183
million. This increase was due to higher income before income taxes
and lower discrete tax benefits compared to the year-ago period,
which included a $249 million benefit from the settlement of a
depreciation-related uncertain tax position.
Net income was $5.63 billion compared with $3.91 billion. EPS was
$5.99 compared with $4.17.
Year-to-date segment results
Our segment results compared with the year-ago period are as
follows:
Analog
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
YTD 2021 |
|
YTD 2020 |
|
Change |
Revenue |
$ |
10,292 |
|
|
$ |
7,759 |
|
|
33 |
% |
Operating profit |
5,295 |
|
|
3,398 |
|
|
56 |
% |
Operating profit % of revenue |
51.4 |
% |
|
43.8 |
% |
|
|
Analog revenue increased in both product lines, led by Signal
Chain. Operating profit increased due to higher revenue and
associated gross profit.
Embedded Processing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
YTD 2021 |
|
YTD 2020 |
|
Change |
Revenue |
$ |
2,285 |
|
|
$ |
1,850 |
|
|
24 |
% |
Operating profit |
881 |
|
|
494 |
|
|
78 |
% |
Operating profit % of revenue |
38.6 |
% |
|
26.7 |
% |
|
|
Embedded Processing revenue increased. Operating profit increased
primarily due to higher revenue and associated gross
profit.
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
YTD 2021 |
|
YTD 2020 |
|
Change |
Revenue |
$ |
935 |
|
|
$ |
776 |
|
|
20 |
% |
Operating profit* |
281 |
|
|
189 |
|
|
49 |
% |
Operating profit % of revenue |
30.1 |
% |
|
24.4 |
% |
|
|
* Includes acquisition charges and restructuring
charges/other |
Other revenue increased $159 million, and operating profit
increased $92 million.
Financial condition
At the end of the third quarter of 2021, total cash (cash and cash
equivalents plus short-term investments) was $9.78 billion, an
increase of $3.21 billion from the end of 2020.
Accounts receivable were $1.65 billion, an increase of
$239 million compared with the end of 2020. Days sales
outstanding for the third quarter of 2021 were 32 compared with 31
at the end of 2020.
Inventory was $1.86 billion, a decrease of $92 million
from the end of 2020. Days of inventory for the third quarter of
2021 were 112 compared with 123 at the end of 2020.
Liquidity and capital resources
Our primary source of liquidity is cash flow from operations.
Additional sources of liquidity are cash and cash equivalents,
short-term investments and a variable-rate, revolving credit
facility. Cash flows from operating activities for the first nine
months of 2021 were $6.40 billion, an increase of
$2.39 billion from the year-ago period due to higher net
income and lower cash used for working capital.
Our revolving credit facility is with a consortium of
investment-grade banks and allows us to borrow up to $2 billion
until March 2024. This credit facility also serves as support for
the issuance of commercial paper. As of September 30, 2021, our
credit facility was undrawn, and we had no commercial paper
outstanding.
Investing activities for the first nine months of 2021 used
$1.87 billion compared with providing cash of $74 million
in the year-ago period. Capital expenditures were
$1.18 billion compared with $437 million in the year-ago
period and were primarily for semiconductor manufacturing equipment
and facilities in both periods. We expect our capital expenditures
to continue to increase in future periods. Short-term investments
used cash of $657 million compared with providing cash of
$523 million in the year-ago period.
Financing activities for the first nine months of 2021 used
$1.98 billion compared with $3.70 billion in the year-ago
period. In 2021, we received net proceeds of $1.50 billion from the
issuance of fixed-rate, long-term debt and retired maturing debt of
$550 million. In the year-ago period, we received net proceeds of
$1.50 billion from the issuance of fixed-rate, long-term debt,
and we retired maturing debt of $500 million. Dividends paid were
$2.82 billion compared with $2.49 billion in the year-ago
period, reflecting an increase in the dividend rate. We used
$385 million to repurchase 2.1 million shares of our
common stock compared with $2.54 billion used in the year-ago
period to repurchase 23.3 million shares. Employee exercises
of stock options provided cash proceeds of $325 million
compared with $356 million in the year-ago
period.
We had $5.66 billion of cash and cash equivalents and
$4.12 billion of short-term investments as of September 30,
2021. We believe we have the necessary financial resources and
operating plans to fund our working capital needs, capital
expenditures, dividend and debt-related payments, and other
business requirements for at least the next 12 months.
In October 2021, we completed our acquisition of Micron
Technology’s 300-millimeter semiconductor factory in Lehi, Utah,
for cash consideration of about $900 million.
Non-GAAP financial information
This MD&A includes references to free cash flow and ratios
based on that measure. These are financial measures that were not
prepared in accordance with generally accepted accounting
principles in the United States (GAAP). Free cash flow was
calculated by subtracting capital expenditures from the most
directly comparable GAAP measure, cash flows from operating
activities (also referred to as cash flow from
operations).
We believe that free cash flow and the associated ratios provide
insight into our liquidity, our cash-generating capability and the
amount of cash potentially available to return to shareholders, as
well as insight into our financial performance. These non-GAAP
measures are supplemental to the comparable GAAP
measures.
Reconciliation to the most directly comparable GAAP measures is
provided in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For 12 Months Ended |
|
|
|
September 30, |
|
|
|
2021 |
|
2020 |
|
Change |
Cash flow from operations (GAAP) |
$ |
8,524 |
|
|
$ |
5,768 |
|
|
48 |
% |
Capital expenditures |
(1,392) |
|
|
(600) |
|
|
|
Free cash flow (non-GAAP) |
$ |
7,132 |
|
|
$ |
5,168 |
|
|
38 |
% |
|
|
|
|
|
|
Revenue |
$ |
17,588 |
|
|
$ |
13,735 |
|
|
|
|
|
|
|
|
|
Cash flow from operations as a percentage of revenue
(GAAP) |
48.5 |
% |
|
42.0 |
% |
|
|
Free cash flow as a percentage of revenue (non-GAAP) |
40.6 |
% |
|
37.6 |
% |
|
|
This MD&A also includes references to an annual operating tax
rate, a non-GAAP term we use to describe the estimated annual
effective tax rate, a GAAP measure that by definition does not
include discrete tax items. We believe the term annual operating
tax rate helps differentiate from the effective tax rate, which
includes discrete tax items.
Long-term contractual obligations
Information regarding long-term contractual obligations is in Item
7 of our Form 10-K for the year ended December 31, 2020.
Additionally, in September 2021, we issued $500 million principal
amount of 1.125% notes maturing in 2026, $500 million principal
amount of 1.90% notes maturing in 2031 and $500 million principal
amount of 2.70% notes maturing in 2051. We retired $550 million of
maturing debt in February 2021.
ITEM 4. Controls and procedures
An evaluation as of the end of the period covered by this report
was carried out under the supervision and with the participation of
management, including our Chief Executive Officer and Chief
Financial Officer, of the effectiveness of the design and operation
of our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934).
Based upon that evaluation, the Chief Executive Officer and Chief
Financial Officer concluded that those disclosure controls and
procedures were effective. In addition, there has been no change in
our internal control over financial reporting (as defined in Rule
13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934)
that occurred during the period covered by this report that has
materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.
PART II – OTHER INFORMATION
ITEM 1A. Risk factors
Information concerning our risk factors is contained in Item 1A of
our Form 10-K for the year ended December 31, 2020, and is
incorporated by reference herein.
ITEM 2. Unregistered sales of equity securities and use of
proceeds
The following table contains information regarding our purchases of
our common stock during the quarter.
ISSUER PURCHASES OF EQUITY SECURITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period |
|
Total Number of Shares Purchased |
|
Average Price Paid per Share |
|
Total Number of Shares Purchased as Part of Publicly Announced
Plans or Programs (a)
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under
the Plans or Programs (a)
|
July 1, 2021 through July 31, 2021 |
|
264,068 |
|
|
|
$ |
187.33 |
|
|
|
245,473 |
|
|
|
$ |
10.34 |
|
billion |
August 1, 2021 through August 31, 2021 |
|
378,737 |
|
|
|
188.82 |
|
|
|
378,737 |
|
|
|
10.27 |
|
billion |
September 1, 2021 through September 30, 2021 |
|
112,060 |
|
|
|
189.21 |
|
|
|
112,060 |
|
|
|
10.25 |
|
billion |
Total |
|
754,865 |
|
(b) |
|
$ |
188.36 |
|
(b) |
|
736,270 |
|
|
|
$ |
10.25 |
|
billion (c) |
(a)All
open-market purchases during the quarter were made under the
authorization from our board of directors to purchase up to $12.0
billion of additional shares of TI common stock announced
September 20, 2018.
(b)In
addition to open-market purchases, 18,595 shares of common stock
were surrendered by employees to satisfy tax withholding
obligations in connection with the vesting of restricted stock
units.
(c)As
of September 30, 2021, this amount consisted of the remaining
portion of the $12.0 billion authorized in September 2018. No
expiration date has been specified for this
authorization.
ITEM 5. Other information
Section 13(r) of the Securities Exchange Act of 1934
disclosure
During the period covered by this report and as permitted by
General License 1B from the U.S. Office of Foreign Assets Control,
we engaged with the Russian Federal Security Service (FSB) solely
to permit the import, distribution and use of certain of our
catalog semiconductor products in Russia. No gross revenue or net
profit is directly attributable to these engagements with the FSB,
and we intend to continue them to the extent permitted by
law.
ITEM 6. Exhibits
|
|
|
|
|
|
|
|
|
Designation of Exhibits in This Report |
|
Description of Exhibit |
3(a) |
|
|
3(b) |
|
|
4(a) |
|
|
31(a) |
|
|
31(b) |
|
|
32(a) |
|
|
32(b) |
|
|
101.ins |
|
XBRL Instance Document – the instance document does not appear in
the Interactive Data File because its XBRL tags are embedded within
the Inline XBRL document.† |
101.def |
|
XBRL Taxonomy Extension Definition Linkbase Document.† |
101.sch |
|
XBRL Taxonomy Extension Schema Document.† |
101.cal |
|
XBRL Taxonomy Extension Calculation Linkbase Document.† |
101.lab |
|
XBRL Taxonomy Extension Label Linkbase Document.† |
101.pre |
|
XBRL Taxonomy Extension Presentation Linkbase
Document.† |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL
document).† |
† Filed or furnished herewith. |
Notice regarding forward-looking statements
This report includes forward-looking statements intended to qualify
for the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements generally can be identified by phrases such as TI or its
management “believes,” “expects,” “anticipates,” “foresees,”
“forecasts,” “estimates” or other words or phrases of similar
import. Similarly, statements herein that describe TI’s business
strategy, outlook, objectives, plans, intentions or goals also are
forward-looking statements. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
We urge you to carefully consider the following important factors
that could cause actual results to differ materially from the
expectations of TI or our management:
•The
duration and scope of the COVID-19 pandemic, government and other
third-party responses to it and the consequences for the global
economy, including to our business and the businesses of our
suppliers, customers and distributors;
•Economic,
social and political conditions, and natural events in the
countries in which we, our customers or our suppliers operate,
including global trade policies;
•Market
demand for semiconductors, particularly in the industrial and
automotive markets, and customer demand that differs from
forecasts;
•Our
ability to compete in products and prices in an intensely
competitive industry;
•Evolving
cybersecurity and other threats relating to our information
technology systems or those of our customers or
suppliers;
•Our
ability to successfully implement and realize opportunities from
strategic, business and organizational changes, or our ability to
realize our expectations regarding the amount and timing of
associated restructuring charges and cost savings;
•Our
ability to develop, manufacture and market innovative products in a
rapidly changing technological environment, and our timely
implementation of new manufacturing technologies and installation
of manufacturing equipment;
•Availability
and cost of raw materials, utilities, manufacturing equipment,
third-party manufacturing services and manufacturing
technology;
•Product
liability, warranty or other claims relating to our products,
manufacturing, delivery, services, design or communications, or
recalls by our customers for a product containing one of our
parts;
•Compliance
with or changes in the complex laws, rules and regulations to which
we are or may become subject, or actions of enforcement
authorities, that restrict our ability to operate our business or
subject us to fines, penalties or other legal
liability;
•Changes
in tax law and accounting standards that impact the tax rate
applicable to us, the jurisdictions in which profits are determined
to be earned and taxed, adverse resolution of tax audits, increases
in tariff rates, and the ability to realize deferred tax
assets;
•A
loss suffered by one of our customers or distributors with respect
to TI-consigned inventory;
•Financial
difficulties of our distributors or semiconductor distributors’
promotion of competing product lines to our detriment; or disputes
with current or former distributors;
•Losses
or curtailments of purchases from key customers or the timing and
amount of distributor and other customer inventory
adjustments;
•Our
ability to maintain or improve profit margins, including our
ability to utilize our manufacturing facilities at sufficient
levels to cover our fixed operating costs, in an intensely
competitive and cyclical industry and changing regulatory
environment;
•Our
ability to maintain and enforce a strong intellectual property
portfolio and maintain freedom of operation in all jurisdictions
where we conduct business; or our exposure to infringement
claims;
•Instability
in the global credit and financial markets;
•Increases
in health care and pension benefit costs;
•Our
ability to recruit and retain skilled personnel, and effectively
manage key employee succession; and
•Impairments
of our non-financial assets.
For a more detailed discussion of these factors, see the Risk
factors discussion in Item 1A of our most recent Form 10-K. The
forward-looking statements included in this report are made only as
of the date of this report, and we undertake no obligation to
update the forward-looking statements to reflect subsequent events
or circumstances. If we do update any forward-looking statement,
you should not infer that we will make additional updates with
respect to that statement or any other forward-looking
statement.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
TEXAS INSTRUMENTS INCORPORATED |
|
|
|
|
|
By: |
/s/ |
Rafael R. Lizardi |
|
|
|
Rafael R. Lizardi |
|
|
|
Senior Vice President and |
|
|
|
Chief Financial Officer |
Date: October 27, 2021
Texas Instruments (NASDAQ:TXN)
Historical Stock Chart
From Apr 2022 to May 2022
Texas Instruments (NASDAQ:TXN)
Historical Stock Chart
From May 2021 to May 2022